RLH Capital's Q3 2026 letter is out, coinciding with our 5-year anniversary!
We discuss widening SPAC yields, improving supply dynamics, and why we believe today's market offers an increasingly attractive opportunity set.
Grateful to everyone who has supported us along the way.
https://t.co/QKs7C1kDFO
What if Jensen Huang turns out to be this generation’s Lou Pai?
For those unfamiliar, Pai was a senior Enron executive who had an affair with a stripper, triggering a divorce that forced him to sell ~$270M of Enron stock.
The timing was impeccable. Enron shares subsequently collapsed.
Recent SPAC extensions have brought renewed attention to non-redemption agreements (NRAs). Here's how we evaluate them:
Our approach starts with the math.
When a SPAC extends its maturity by one year, it goes from effectively zero remaining duration to 12 months. Its share price must reprice to offer new investors the prevailing market yield.
Assuming a 6% required SPAC yield and a 3.8% money market rate, we would expect the SPAC to trade down approximately $0.22 following redemptions.
For an NRA participant, that expected price decline represents the economic cost of receiving founder shares in exchange for not redeeming.
The implied cost to create a founder share at various coverage levels:
10% coverage: $2.20
20% coverage: $1.10
30% coverage: $0.73
40% coverage: $0.55
Shorter extensions (6 or 9 months) reduce the implied creation cost, but increase execution risk by leaving less time to consummate a transaction.
Now consider the alternatives:
1. Original risk capital: Typically raised at an implied $0.75–$1.25 per founder share, depending on sponsor and underwriter.
2. SPAC rights: The median right among SPACs still seeking a business combination implies a creation price of approximately $0.80 per share, with the benefit of immediate liquidity.
For SPACs with publicly traded rights and warrants, participating in an NRA is a proactive decision to source exposure through an illiquid agreement rather than purchasing liquid securities in the market.
One important distinction: Not all NRA participants have the same incentives.
Existing risk capital investors may accept less attractive NRA economics to preserve the optionality of their original investment. Similarly, large warrant or rights holders may participate on less favorable terms to preserve the value of their existing derivative exposure.
These investors are evaluating the NRA in the context of their broader holdings, not necessarily as an attractive standalone investment.
Our conclusion:
NRAs can be compelling, but the economics must justify the complexity, illiquidity and execution risk.
We generally expect to create founder shares at a meaningful discount to both the original risk capital and publicly traded rights, particularly given the shorter remaining transaction window versus when the original risk capital was committed.
The objective isn't simply to acquire founder shares. It's to acquire them at a sufficiently attractive price relative to the alternatives.
$BACC $BACCR
Form EFFECT out this morning which means final prospectus likely to come tonight or monday.
20-30 days for vote would imply 11/12 to 11/22
Min cash previously waived, and prepayent received from @CoreWeave
BTIG underwritten SPACs have been closing quick, if that trend continues here, should close by Thanksgiving
$BACC $BACCR
Form EFFECT out this morning which means final prospectus likely to come tonight or monday.
20-30 days for vote would imply 11/12 to 11/22
Min cash previously waived, and prepayent received from @CoreWeave
BTIG underwritten SPACs have been closing quick, if that trend continues here, should close by Thanksgiving
$IVAI
Given all the chat about @OpenAI during the $IVAI roadshow I wonder if we could hear something in the coming weeks.
OpenAI told investors Thursday that it aims to secure signatures by the end of next week. The final size of the round is still being determined, the people said.
The San Francisco-based AI company is raising up to $30 billion at a $1.25 trillion valuation
https://t.co/8VL1N8Sljz
$IVAI
This is pretty interesting. Curious to see how the market prices it.
Structured somewhat like a SPAC (redemption rights), @DivesTech and team will have up to a year to acquire stakes in one or more private companies. @OpenAI came up frequently — unclear whether simply as an example or something they are actively pursuing.
The key question: will investors pay a premium to NAV for access to private companies they otherwise can’t own?
For that premium to persist, the market needs to believe appreciation in the underlying portfolio will more than offset the premium paid for access.
At the IPO price, the yield is roughly in line with the median SPAC, but there are no warrants or rights. Historically, warrantless SPACs have tended to trade at a premium to the broader group.
So what is $IVAI and how will it trade?
A SPAC?
A warrantless SPAC?
Or something the market prices entirely differently?
Should be interesting to watch.
Today marks 5 years since the launch of RLH Capital!
I'm incredibly grateful to our investors for their trust, our partners and service providers for their support, and the Twitter community for the insights, discussions, and relationships along the way.
Proud of what we've built and excited for what's ahead!
And for anyone considering starting their own fund, my DMs are always open. Happy to share what I've learned along the way.
@vik_mittal@SPACuity@blangb@SPACMAN17 $ADER team was also buying warrants, although that obviously turned into a mess
So @vik_mittal seems like sponsors can buy the underlying warrants and/or rights if they think the security is undervalued! :)
One of the more striking trends in SPACs has been the poor trading performance of warrants and rights, particularly among announced deals.
Across 69 exchange-listed SPACs, the median warrant trades at just $0.23, while the median rights-implied share price is $1.11.
Despite these depressed valuations, I have yet to see a single insider purchase. Correct me if I'm wrong.
This is exactly what the market is desperately missing. If sponsors believe their deals are worth substantially more than the market suggests, it's time to put their money where their mouths are.
@SPACMAN17 Its been done before pre-closing. I'm not a lawyer but I would imagine just after filing an S/F-4 there should be a window where you can buy.
Not dissimilar from management buying after earnings even though sure, they probably know some things
$XRPN $XRPNW @evernorthxrp Updated Estimated NAV: $8.43/share
Following this morning's 8-K, we've updated our NAV calculation. Please do your own diligence and feel free to flag any errors.
Share Count
23.64mm Class A shares
31.39mm Class C shares
22.95mm Pathfinder units
77.98mm basic shares
Both Class C shares and Pathfinder units are convertible/exchangeable into Class A on a 1:1 basis.
After accounting for warrant and convertible debt dilution based on the current trading price, we estimate 84.8mm diluted shares.
NAV Calculation
473mm XRP valued at ~$645mm ($1.36/XRP)
$75.7mm pro forma cash
$6.18mm related-party payables
~$715mm net assets
84.8mm diluted shares
Estimated NAV: $8.43/share
This calculation has been more complicated than it should be, largely because Pathfinder units were disclosed separately from Class A and Class C shares, making the total economic share count difficult to reconcile.
Sources:
Updated share count (Oct. 13):
https://t.co/Bnl5bHQn9e
Pro forma balance sheet:
https://t.co/tUzqWLCK9y
$XRPN $XRPNW – Updated Estimated NAV: $8.43/share
Following this morning's 8-K, we've updated our NAV calculation. Please do your own diligence and feel free to flag any errors.
Share Count
23.64mm Class A shares
31.39mm Class C shares
22.95mm Pathfinder units
77.98mm basic shares
Both Class C shares and Pathfinder units are convertible/exchangeable into Class A on a 1:1 basis.
After accounting for warrant and convertible debt dilution based on the current trading price, we estimate 84.8mm diluted shares.
NAV Calculation
473mm XRP valued at ~$645mm ($1.36/XRP)
$75.7mm pro forma cash
$6.18mm related-party payables
~$715mm net assets
84.8mm diluted shares
Estimated NAV: $8.43/share
This calculation has been more complicated than it should be, largely because Pathfinder units were disclosed separately from Class A and Class C shares, making the total economic share count difficult to reconcile.
Sources:
Updated share count (Oct. 13):
https://t.co/Bnl5bHQn9e
Pro forma balance sheet:
https://t.co/tUzqWLCK9y
$XRPN – A great outcome for the company, with the exercise of $XRPNW warrants starting on Monday providing additional capital at $11.50
Warrant exercises followed by an S-1 registration should also help establish a more normalized trading float
Unfortunately, outcomes like this remain the exception rather than the rule, but this is exactly what most SPAC teams hope to achieve
We estimate that over the next 4 weeks ~$2.5bn of SPAC paper will be up for redemption either as part of an extension or transaction vote
Will be interesting to see how those proceeds will be reinvested
$IVAI
This is pretty interesting. Curious to see how the market prices it.
Structured somewhat like a SPAC (redemption rights), @DivesTech and team will have up to a year to acquire stakes in one or more private companies. @OpenAI came up frequently — unclear whether simply as an example or something they are actively pursuing.
The key question: will investors pay a premium to NAV for access to private companies they otherwise can’t own?
For that premium to persist, the market needs to believe appreciation in the underlying portfolio will more than offset the premium paid for access.
At the IPO price, the yield is roughly in line with the median SPAC, but there are no warrants or rights. Historically, warrantless SPACs have tended to trade at a premium to the broader group.
So what is $IVAI and how will it trade?
A SPAC?
A warrantless SPAC?
Or something the market prices entirely differently?
Should be interesting to watch.
Agree on NAV Calc. Potentially imporved by PIPE (If they do a PIPE sized the same as post-tender trust, I est. NAV increases to $8.35).
My understanding is the AI portfolio will be announced prior to tender. So investors will need to decide if it's worth paying 1.35x NAV for the portfolio.
Will be interesting to see how they frame that pitch.
$IVAI
This is pretty interesting. Curious to see how the market prices it.
Structured somewhat like a SPAC (redemption rights), @DivesTech and team will have up to a year to acquire stakes in one or more private companies. @OpenAI came up frequently — unclear whether simply as an example or something they are actively pursuing.
The key question: will investors pay a premium to NAV for access to private companies they otherwise can’t own?
For that premium to persist, the market needs to believe appreciation in the underlying portfolio will more than offset the premium paid for access.
At the IPO price, the yield is roughly in line with the median SPAC, but there are no warrants or rights. Historically, warrantless SPACs have tended to trade at a premium to the broader group.
So what is $IVAI and how will it trade?
A SPAC?
A warrantless SPAC?
Or something the market prices entirely differently?
Should be interesting to watch.